Literature DB >> 16482443

Genetic mutation screening for the low-density lipoprotein receptor.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16482443     DOI： 10.1007/s00109-006-0038-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  5 in total

1.  Targeting high-risk young patients for statin therapy.

Authors:  Antonio M Gotto
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

2.  Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands.

Authors:  M A Umans-Eckenhausen; J C Defesche; E J Sijbrands; R L Scheerder; J J Kastelein
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

3.  Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.

Authors:  Steve E Humphries; Treena Cranston; Marcus Allen; Helen Middleton-Price; Maryam C Fernandez; Victoria Senior; Emma Hawe; Andrew Iversen; Richard Wray; Martin A Crook; Anthony S Wierzbicki
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

4.  Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.

Authors:  Albert Wiegman; Barbara A Hutten; Eric de Groot; Jessica Rodenburg; Henk D Bakker; Harry R Büller; Eric J G Sijbrands; John J P Kastelein
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

5.  Oligonucleotide ligation assay (OLA) for the diagnosis of familial hypercholesterolemia.

Authors:  H Baron; S Fung; A Aydin; S Bähring; F C Luft; H Schuster
Journal:  Nat Biotechnol       Date:  1996-10       Impact factor: 54.908
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.